Armata Pharmaceuticals (ARMP) vs enGene Therapeutics (ENGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Armata Pharmaceuticals (ARMP) has outperformed enGene Therapeutics (ENGN) over the past year, gaining 21.3% versus a loss of 75.1%. Armata Pharmaceuticals is the larger company by market cap ($143.5 million vs $119.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARMP | ENGN |
|---|---|---|
| Share price | $3.86 | $1.78 |
| Market cap | $143.52M | $119.29M |
| 1-day change | +1.31% | +2.01% |
| YTD return | -39.33% | -80.68% |
| 1-year return | +21.34% | -75.11% |
| 5-year return | +10.43% | — |
| EPS (TTM) | $-5.29 | $-2.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.34 | $12.25 |
| 52-week low | $3.09 | $1.40 |
| Distance from 52-week high | -76.38% | -85.47% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +353.37% | — |
| Average volume | 210.93K | 746.58K |
| Shares outstanding | 37.18M | 67.02M |
| Employees | 61 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ARMP has outperformed ENGN by 96.4 percentage points over the past year.
About Armata Pharmaceuticals
ARMP stock →Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 61 employees
ARMP vs ENGN FAQ
Which is bigger, Armata Pharmaceuticals or enGene Therapeutics?
Armata Pharmaceuticals (ARMP) is larger, with a market capitalization of $143.52M compared with $119.29M for enGene Therapeutics (ENGN).
Which stock has performed better over the past year, ARMP or ENGN?
ARMP returned +21.34% over the past 12 months, compared with -75.11% for ENGN (price return, excluding dividends). Past performance does not predict future results.
Are Armata Pharmaceuticals and enGene Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.